Cramer would never cover NWBO as an OTC penny stock. No mainstream media will do it. I’ve tried to explain that for years. It’s a no go. The only way they get coverage is indirectly, mentioning maybe the company in an article about DCVax-L but most of the headline and story would be about Dr. Liau, etc. or, just a small reference, no ticker. No financial network will cover it. That won’t happen at all until they are in a major exchange and then mainly in financial news.
I would not get hopes up for a NYTimes spread about how they survived AF.
What will change things are deals and revenue streams. Getting approval is on the road to revenue both.
I’d say from the look of some posts here tonight, just IMHO, some people want to buy shares as cheaply as possible before approval.
Market Data 
Markets 
AI
